← All companies
Monte Rosa Therapeutics, Inc.
GLUE - CIK 0001826457
Market cap$1.39 B
Rank#2397
SEC filings352
The table below shows Monte Rosa Therapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $129.88M | $224.25M | $128.10M | $54.91M | $346.07M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $393.19M | $377.44M | $236.21M | $275.89M | $348.67M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.